Back

Drug resistance-associated mutations in Plasmodium UBP-1 disrupt ubiquitin hydrolysis

Smith, C.; Henrici, R.; Karpiyevich, M.; Ansbro, M. R.; Hoshizaki, J.; van der Heden van Noort, G. J.; Ascher, D. B.; Sutherland, C. J.; Lee, M. C. S.; Artavanis-Tsakonas, K.

2022-09-15 microbiology
10.1101/2022.09.15.508122 bioRxiv
Show abstract

Deubiquitinating enzymes function to cleave ubiquitin moieties from modified proteins, serving to maintain the pool of free ubiquitin in the cell while simultaneously impacting the fate and function of a target protein. Like all eukaryotes, Plasmodium parasites rely on the dynamic addition and removal of ubiquitin for their own growth and survival. While humans possess around 100 DUBs, Plasmodium contains [~]20 putative ubiquitin hydrolases, many of which bear little to no resemblance to those of other organisms. In this study, we characterize PfUBP-1, a large ubiquitin hydrolase unique to Plasmodium spp that has been linked to endocytosis and drug resistance. We demonstrate its ubiquitin activity, linkage specificity and assess the repercussions of point mutations associated with drug resistance on catalytic activity and parasite fitness.

Matching journals

The top 6 journals account for 50% of the predicted probability mass.

50% of probability mass above

"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.